MUSC Catalyst News

Hollings Cafe's Jose and Wendy Perey offer food and kindness to patients and staff. Through quiet donations to Hollings, they've hit a big milestone in giving.

Knowing that past research made treatment of her salivary gland cancer possible, Michelle Brown-Nelson wanted to donate an unexpected windfall to new research.

Most people with an inherited mutation that increases cancer risk have no idea – which is why genetic testing is so important, says Dr. Kevin Hughes.

Caregiving for family members with cancer can take an emotional and physical toll. Yet few caregivers are screened for distress or connected to resources.

New research shows that, for the first time, there are more young people who begin to use nicotine through vaping rather than through cigarettes.

A drug that Hollings researchers were developing for cancer turns out to restore motor function in aging mice showing signs of neurodegeneration.

New program offers specialized fitness and wellness for prostate cancer survivors.

MUSC Hollings Cancer Center researchers believe that some already-approved drugs could be used in certain cases where breast cancer has become resistant.

Thai Ho, M.D., Ph.D., will lead precision oncology efforts at MUSC Hollings Cancer Center.

Even oncology nurses don’t look forward to certain cancer screenings. But everything is better with a friend – even colonoscopies.